Keenova Therapeutics PLC
Keenova Therapeutics's GHG Emissions Data Preview
In 2023, Keenova Therapeutics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Keenova Therapeutics has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Location-Based | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Verified Sources Behind Keenova Therapeutics’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Keenova Therapeutics’s data sources below and access millions more through our Disclosure Search.
Insights into Keenova Therapeutics's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Keenova Therapeutics amounted to 162,999 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Keenova Therapeutics decreased by 5.18%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
Keenova Therapeutics's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Keenova Therapeutics's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Keenova Therapeutics were 89,052 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2022), Keenova Therapeutics's Scope 1 emissions remained relatively stable, indicating that Keenova Therapeutics's emissions have plateaued with no significant change in its operational footprint.a
What are Keenova Therapeutics's Scope 2 emissions?
In 2023, Keenova Therapeutics reported Scope 2 greenhouse gas (GHG) emissions of 74,164 tCO₂e using the market-based method and 73,947 tCO₂e using the location-based method.a
Has Keenova Therapeutics reduced its Scope 2 emissions over time?
Compared to the previous year (2022), Keenova Therapeutics's Scope 2 emissions (Location-Based) fell by 10.2% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a
What methodology does Keenova Therapeutics use for Scope 2 reporting?
In 2023, Keenova Therapeutics reported its Scope 2 emissions using the market-based method and using the location-based method.a
Keenova Therapeutics's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based